By Gareth Kitson, RPS Professional Development and Engagement Lead
I had known for a long time that I was gay but had never had to acknowledge it. I never engaged with the LGBT+ community at Uni as I had a ready-made group of friends. I wasn’t confident enough to engage with members of the community as I felt I had to behave in a certain way. After moving to London I was pushed into the one of the most vibrant and diverse communities in the world and wasn’t ready for the effect it would have on me.
Every aspect of the LGBT+ community had “tribes” or
“communities” and I really struggled to find my place. I also found it really hard to make friends
outside of a dating environment. Most
gay men will tell you the same story – insecurity, isolation and the struggle
to “fit in”.
In July 2012 I was out shopping on Oxford Street and accidentally stumbled on the Pride in London Parade. I felt overwhelmed, curious and confused as to what was happening. I stopped and watched the entire Parade pass by and spent the rest of the day reflecting on what I had just seen.
For the first time, I suddenly felt that I wasn’t
alone. I suddenly realised that there
were other people living in the same city as me who identified as a member of
the LGBT+ community. There were
opportunities to meet people who may have gone through the same experiences as
you, be it coming to terms with your own identity or coming out to your family
This one day showed me that people from all backgrounds can
stand next to each other and be proud of who they are. That families can gather and show their
children that it is OK for a man to love a man and that some of their friends
may have two mummies instead of a mummy and a daddy.
It was heart-warming, confidence-boosting and empowering when I finally realised that I wasn’t alone. That I could live my life as I wanted, being true to who I really was, in the city I now called home. That’s why Pride matters.
Members of staff and members of the RPS will be walking in the Parade on 6th July. If you see us, give us a wave #wearepharmacy.
2019 marks the 50th anniversary of the landmark asthma treatment Salbutamol becoming commercially available in the UK. Salbutamol is still widely used today to relieve symptoms of asthma and COPD such as coughing, wheezing and feeling breathless. It works by relaxing the muscles of the airways into the lungs, making it easier to breathe.
Launched in 1969 with the brand name Ventolin, Salbutamol revolutionised the treatment of bronchial asthma.
It treated bronchospasm far more effectively compared with
previous bronchodilators and had fewer side effects.
To understand how much of a breakthrough Salbutamol was in
the treatment of asthma, it’s first worth comparing it to the drugs that were
used to treat asthma before 1969.
One of the main drugs used for treating asthma in the
mid-1960s was isoprenaline. This is a powerful bronchodilator and was used to
relieve bronchospasm. However, the side effects include a sudden increased
heart rate. Between
1963 and 1968 in the UK there was an increase in deaths among people using
isoprenaline to treat asthma. This was attributed to overdose due to both excessive
use of the aerosols and the high dosage they dispensed.
In the mid-1960s the mortality rate for asthma sufferers had
risen to over 2,000 deaths a year. An effective bronchodilator was desperately
needed that did not stimulate the heart or affect blood pressure.
Salbutamol was discovered in 1966 by a research team at
Allen and Hanburys (a subsidiary of Glaxo). Salbutamol was the first drug that selectively
targeted specific receptors in the lungs, inhibiting the production of proteins
needed to produce muscle contractions. It works by relaxing the smooth muscle
of the airways, opening them up and so lessening or preventing an asthma
attack. Not only was Salbutamol a good bronchodilator, it lasted longer than
isoprenaline, and inhalation caused fewer side effects.
In addition to the effectiveness of the drug, the method of
administration itself was also revolutionary. The Ventolin inhaler was designed
to ensure metered aerosol doses of Salbutamol were inhaled straight into the
The drug was an instant success.
The only real deficiency of Salbutamol was its short
duration of action; at 4 hours it couldn’t prevent night-time asthma attacks.
In response to this the pharmaceutical manufacturer Glaxo aimed to develop a
longer acting drug. The result of their research was
Salmeterol. Launched in 1990 with the brand name Serevent, it had a 12-hour
duration of action.
By Chris Maguire, pharmacist and marketing manager at Beckton Dickinson
I studied pharmacy at Queens University, Belfast.
I completed my pre-reg in community pharmacy, in a small chain, in the same town I went to school. Once I had finished, I did a few locums for the same company and was offered a relief position. I had friends in England who told me about the offers they’ve been receiving. I was tempted…and made the move to the “mainland”. I applied for few jobs and got one with Lloyds pharmacy, living in Liverpool. I moved from relief manager, to pharmacy manager to cluster manager. I was really enjoying work and career progression, but I had always wanted to travel so I took a career break for a year and travelled. I even got to work in a hospital in Sydney for 6 months of my 14 months adventure.
When I came home, I got a job at Interface Clinical Services, working in primary care. Delivering services such as osteoporosis, diabetes and asthma reviews. Again, I started making my way up – from service development, to a national lead pharmacist.
I managed a team of 90 pharmacists running reviews, clinics, hospital work and made sure they were trained. I had always been focused on delivering care based on NICE guidance or the latest evidence in disease areas. I think that with more responsibility, pharmacists can help make a change on a bigger scale.
In my roles in primary care, I learned how clinical systems work in GP land, how the mechanics of QOF work. I strongly believe that with up-skilling pharmacists to be experts in specific disease areas and pharmacy integration we can create better primary care services.
I’d been working on a diabetes service specifically for quite a while and think there is so much more pharmacists could do. It was because of my experience in primary care that I was approached by industry to join as a project manager and help to deliver value based health care. A concept where value is the outcome for the patient over the cost. I thought this was an amazing opportunity to help on a bigger scale and to gain experience in industry.
I had been approached by industry before with an MSL
opportunity. I looked into their portfolio, their evidence, the guidelines and
felt that it wasn’t a good fit and I couldn’t hang my pharmacist hat on that.
So, I stayed with Interface for another 2 years, gaining more experience and
exposure working with federations, CCGs, hospitals, AHSNs, NICE and others.
It’s not always how fast you can get to the new job but going for the right
After working for a year as a project manager, I
applied for a marketing manager job. I didn’t have any experience in marketing,
but I do understand how the NHS and the supply chain works. I understand how the use of data can help
improve outcomes, which helped me get the job! I’ve now also enrolled on a
course to become CIM (Chartered Institute of Marketing) certified at
diploma/degree level to make sure I have all the basics and grounding needed.
The moment has arrived.
RX and I are sitting opposite one another in the Bell Room at RPS
HQ. Messrs Squire and Hills, grandees
from pharmacy history looking down at us from the wall and behind us the
artefacts of the museum (I’m hoping there isn’t a thumbscrew in the museum and
that this is going to be a free flowing discussion).
Dowdall – Executive Editor, Research & Learning
April 2019 marked a year since the launch of the RPS MyCPD
app, which contains content from The
Pharmaceutical Journal and Clinical
Pharmacist. Its aim is to meet the needs of members and pharmacy
professionals undergoing revalidation. And it seems to be doing just that – in
quarter one 2019, around 1,000 users were accessing content through the RPS
MyCPD app every month, completing over 1,400 records of their learning and CPD
activities. With updates scheduled over the coming months, the additional
revalidation requirements for peer discussion and reflective accounts, as well
as over 330 articles from Pharmaceutical Journal Publications now available,
this number is certain to grow.
Contributors from Korle-Bu Teaching Hospital in Ghana: Dr Daniel Ankrah, Mark Harrison, Tony Osei, Priscilla Ekpale, Julia Selby, Jennifer Laryea, Asiwome Aggor, Frempomaa Nelson, Helena Owusu, Grace Aboagye and Agnetta Ampomah
The Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) educates, trains and supports overseas health workers to tackle the growing challenge of antimicrobial resistance. Partnerships are running in Ghana, Tanzania, Uganda and Zambia, with the support of UK health workers including pharmacists.
Here, the Korle-Bu Teaching Hospital in Ghana – North Middlesex University Hospital NHS Trust (NMUH) partnership to explore their motivations and hopes for their project.
I graduated with a master’s degree in pharmacy from Queen’s University Belfast.I undertook my pre-registration year in a community pharmacy chain in Northern Ireland. I was employed as a pharmacist manager with the same company post pre-registration year. I spent a further four years as a community pharmacist.
I thoroughly enjoyed this role, especially being a pharmacist tutor. This very much sparked my interest in training others. I had always been curious about alternative pharmacist roles, but felt my knowledge of career paths was limited.
As pharmacists, we need to know that the
services we provide are effective, safe, and efficient. This way we can make
sure patients are getting the care they need and deserve. We also need to know
that the services are continuing to meet the requirements of an ever-changing
By Tarquin Bennett – Coles, Principle Consultant at Carmichael Fisher
The Life science sector is a vibrant and constantly changing environment that can suit those who like to take educated risks with start-up ventures or those who want a more secure long-term career within a large organisation. Getting into the sector is still people/connection based so establishing a network and reliable advocates will help you make the first step. If you can find a person you can interact with rather than using an online portal then this will improve your chances.
Deciding on the right role and company for you will require some due diligence on the company values and culture. Most of this can be achieved online. Glassdoor is a useful tool to see what people say about a business, good and bad.
Nevertheless, having someone you can talk to who actually works at the company you are interested in is even more useful. If you can use your network to help you achieve this, then it will give you a head start.
To make the right step also requires some realistic self-assessment.
You can use online tools for this or If you can find someone you work with and ask them how you come across in meetings or day to day you can find out a great deal about how you are perceived. It is also worth thinking about what motivates you, what will drive you to get up for work or travel a long way for a meeting? Do you like to work in a group or independently? Even at an early stage it is well worth thinking about where you would like to land after the role you are applying for. Having this in mind will help you weigh up the potential of the position now and as part of your broader career aspirations even if they change.
Some individuals choose to join the sector via a service organisation then move across to biophama or MedTech businesses once they have their network in place. This includes joining life science teams in the large consulting houses (PwC, E&Y, McKinsey etc), boutique players (Huron, Cambridge Consultants, Sagentia), outsourcing businesses like a Contract or Clinical Research Organisations (CROs – IQVIA, Paraxel, Covance etc) or biopharma sales companies.
Others, choose to start out in a corporate setting via the City (equity analysis), private equity or venture capital businesses and then transition across.
In addition, the emerging data and digital space means some technology players (Amazon, Google, Apple, Samsung etc) are moving into the healthcare sector and they require experts with an understanding of life sciences sector so this may also offer a way in. Hot areas of growth also include diagnostics & biomarker businesses, AI/Machine Learning, data science and digital health companies.
Once you have gained some experience, or if you want to make the step immediately, then there are some key skills and experiences that companies most value. If you can highlight these when you apply or at interview then they will help differentiate you and increase your chances of an offer.
Demonstrable track record of success.
Examples of persuasion and influence whilst working outside your area of management control
The ability to prioritise between the urgent and important.
Expertise at working to tight deadlines and dealing with a fast paced environment for service delivery & communication (this should suit all pharmacists).
Project management skills & the ability to switch focus/direction due rapid market shifts or new convergent technologies.
Right now certain functions and disciplines are in particularly high demand. These include, analytics, data science, informatics, medical affairs and information, toxicology, pharmacology, business development, clinical development, regulatory affairs, market access and pricing and reimbursement.
Another thing to consider before you join the industry is to choose a location where there is a cluster of companies and sector support businesses already located there. This will increase the opportunity for you to progress and find alternative work if the position does not work out or the company goes through a major transformation or acquisition. In 2019 we are seeing some major merger and acquisition activity. Most successful clusters (Cambridge, London, Oxford, Edinburgh, Manchester, and Cardiff etc) will also have good transport links, access to funding streams, academic and research hubs, hospitals and service businesses nearby.
Once you make the step do remember you are likely to be joining a sector where there will be five generations in the workplace (Gen Z – 18yrs old in 2018). Each generation defines success and working habits with a slightly different perspective so it is worth considering that if you are working in a cross-generational team or have a line manager from a different era.
In terms of what lies ahead you have a myriad of choices once you break into the sector so keep checking in on your own plans. Leadership agility is being highlighted as a future “must have” and so is some international experience so if you can add those to your existing skill set, then you will be in a good place to progress. Similarly, there are now more industry collaborations and partnerships than ever before so involvement in such projects will help you stand out. Good luck, you have an exciting future ahead.
QPs assure the quality of our medicines, so it’s important
they’re well trained and fully understand how pharmaceuticals are manufactured.
As a QP you’ll be legally responsible for certifying batches of medicinal products before they’re used in clinical trials or available on the market. You’ll also need to understand the factors that can affect the safety of medicines and supply chains.
The Royal Pharmaceutical Society is the dedicated professional body for pharmacists and pharmacy in England, Scotland and Wales.
Our blogs are written by experts and provide thought provoking information and commentary on health, health policy issues and lifestyle choices. Here you will find opinions and comments on topics related to public health and medicine safety.
We work with a variety of health, charity and business partners to help us highlight particular health issues and run successful health campaigns. We will be inviting guest bloggers from these organisations to help us create interesting, varied and engaging public content.